Neuromics is proud to introduce their newest pioneering research tools – human Cas9 expressing primary cells and GPCR expressing cell lines.
Cas9 Expressing Primary Cells & GPCR Expressing Cell Lines


Neuromics is proud to introduce their newest pioneering research tools – human Cas9 expressing primary cells and GPCR expressing cell lines.

Comparison study data between Flow Cytometry antibodies from Elabscience, BioLegend and BD Biosciences.

KACTUS have developed a dsRNA Quick-Quantification Kit to detect the presence of undesired dsRNA molecules in IVT reactions or dsRNA in viral/non-viral nucleic acid extracts.

KACTUS has carefully developed a highly sensitive spCas9 detection kit.

KACTUS has developed a series of high-activity enzyme for in vitro synthesis of DNA vectors, based on their SAMS™ technology platform.

KACTUS have used their SAMS™ protein production platform to develop high-quality enzymes for in vitro synthesis of mRNA (GMP-Grade & GMP-Ready).

KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.

At KACTUS, they have developed a highly-active, wild-type Cas9 nuclease based on their SAMS™ technology platform.

AccuBase® is a cytosine base editor that converts a C-G base pair into a T-A base pair in the genome. Designed by Base Therapeutics, manufactured by KACTUS.

KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.